Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on March 27, 2007
J Am Soc Nephrol 18: 1497-1507, 2007
© 2007 American Society of Nephrology
doi: 10.1681/ASN.2005080866

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2005080866v1
18/5/1497    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, S.-H.
Right arrow Articles by Kim, Y.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, S.-H.
Right arrow Articles by Kim, Y.-L.

Pathophysiology of Renal Disease and Progression

Erythropoietin Decreases Renal Fibrosis in Mice with Ureteral Obstruction: Role of Inhibiting TGF-beta–Induced Epithelial-to-Mesenchymal Transition

Sun-Hee Park*, Min-Jeong Choi*,{dagger}, In-Kyung Song{dagger}, Soon-Youn Choi*,{dagger}, Ju-Ock Nam{dagger}, Chan-Duck Kim*, Byung-Heon Lee{dagger}, Rang-Woon Park{dagger}, Kwon Moo Park{ddagger}, Yong-Jin Kim§, In-San Kim{dagger}, Tae-Hwan Kwon{dagger} and Yong-Lim Kim*

* Division of Nephrology and Department of Internal Medicine, {dagger} Department of Biochemistry and Cell Biology, and {ddagger} Department of Anatomy, Kyungpook National University School of Medicine, and § Department of Pathology, Yeungnam University College of Medicine, Daegu, Korea

Address correspondence to: Dr. Yong-Lim Kim, Division of Nephrology and Department of Internal Medicine, Kyungpook National University Hospital, 50 Samduk-dong 2Ga, Jung-gu, Daegu 700-721, Korea. Phone: +82-53-420-5553; Fax: +82-53-423-7583; E-mail: ylkim{at}knu.ac.kr or Dr. Tae-Hwan Kwon, Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, Daegu, 700-422 Korea. Phone: +82-53-420-4825, Fax: +82-53-422-1466; E-mail: thkwon{at}knu.ac.kr

Received for publication August 19, 2005. Accepted for publication February 3, 2007.

The inhibitory effects of recombinant human erythropoietin (rhEPO) were examined against (1) the progression of renal fibrosis in mice with complete unilateral ureteral obstruction and (2) the TGF-beta1–induced epithelial-to-mesenchymal transition (EMT) in MDCK cells. Unilateral ureteral obstruction was induced in BALB/c mice and rhEPO (100 or 1000 U/kg, intraperitoneally, every other day) or vehicle was administered from day 3 to day 14. Immunoblotting and immunohistochemistry revealed increased expressions of TGF-beta1, {alpha}-smooth muscle actin ({alpha}-SMA), and fibronectin and decreased expression of E-cadherin in the obstructed kidneys. In contrast, rhEPO treatment significantly attenuated the upregulation of TGF-beta1 and {alpha}-SMA and the downregulation of E-cadherin. MDCK cells were treated with TGF-beta1 (5 ng/ml) for 48 h to induce EMT, and the cells were then co-treated with TGF-beta1 and rhEPO for another 48 h. Increased expressions of {alpha}-SMA and vimentin and decreased expressions of zona occludens–1 and E-cadherin were observed after TGF-beta1 treatment, and these changes were markedly attenuated by rhEPO co-treatment. TGF-beta1 increased phosphorylated Smad-2 expression in MDCK cells, which was decreased by rhEPO co-treatment. In conclusion, rhEPO treatment inhibits the progression of renal fibrosis in obstructed kidney and attenuates the TGF-beta1–induced EMT. It is suggested that the renoprotective effects of rhEPO could be mediated, at least partly, by inhibition of TGF-beta1–induced EMT.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
J.-H. Kie, M. H. Kapturczak, A. Traylor, A. Agarwal, and N. Hill-Kapturczak
Heme Oxygenase-1 Deficiency Promotes Epithelial-Mesenchymal Transition and Renal Fibrosis
J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1681 - 1691.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. Boor, K. Sebekova, T. Ostendorf, and J. Floege
Treatment targets in renal fibrosis
Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3391 - 3407.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP